The Safety Net Foundation is a nonprofit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost. Products supported by the Safety Net Foundation covers Aranesp® (darbepoetin), EPOGEN® (epoetin) for dialysis use only, Neulasta® (pegfilgrastim), NEUPOGEN® (filgrastim), Nplate® (romiplostim), Prolia® (denosumab) injection, Sensipar® (cinacalcet), Vectibix® (panitumumab) injection, and XGEVA® (denosumab).
Programs Offered
Therapies Offered
-
Aranesp®
-
EPOGEN®
-
Neulasta®
-
Neupogen®
-
Nplate®
-
Prolia®
-
Sensipar®
-
Vectibix®
-
XGEVA®
The information provided on this page was provided by The Safety Net Foundation. For information about specific prescription drugs, including the FDA-approved prescribing information, please visit www.amgen.com.